SEC Filings

Filing date	Form	Description	View
08/05/22	SC TO-I/A	Amendment to a previously filed SC TO-I	View HTML 0001104659-22-086480.pdf 0001104659-22-086480.rtf 0001104659-22-086480.xls
08/05/22	CORRESP	CORRESP	View HTML 0001104659-22-086485.pdf 0001104659-22-086485.rtf
08/04/22	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-22-086148.pdf 0001104659-22-086148.rtf 0001104659-22-086148.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
08/03/22	SC 13D/A	An amendment to a SC 13D filing	View HTML 0001387131-22-008328.pdf 0001387131-22-008328.rtf 0001387131-22-008328.xls
08/01/22	UPLOAD	UPLOAD	View HTML 0000000000-22-008020.pdf 0000000000-22-008020.rtf
07/27/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-008006.pdf 0001415889-22-008006.rtf 0001415889-22-008006.xls
07/26/22	SC TO-I	Tender offer schedule and amendment filed by the issuer.	View HTML 0001104659-22-082630.pdf 0001104659-22-082630.rtf 0001104659-22-082630.xls
07/20/22	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-22-081147.pdf 0001104659-22-081147.rtf 0001104659-22-081147.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
07/14/22	SC TO-C	Written public communication relating to an issuer or third party tender offer	View HTML 0001104659-22-079664.pdf 0001104659-22-079664.rtf 0001104659-22-079664.xls
07/14/22	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-22-079655.pdf 0001104659-22-079655.rtf 0001104659-22-079655.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.